Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease

被引:45
作者
Siderowf, Andrew
Jennings, Danna
Connolly, James
Doty, Richard L.
Marek, Kenneth
Stern, Matthew B.
机构
[1] Univ Penn, Dept Neurol, Parkinsons Dis & Movement Disorders Ctr, Philadelphia, PA 19104 USA
[2] Inst Neurodegenerat Disorders, New Haven, CT USA
[3] Univ Penn, Ctr Smell & Taste, Philadelphia, PA 19104 USA
关键词
olfaction; Parkinson's disease; caffeine; risk factors; family history;
D O I
10.1002/mds.21707
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first-degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Idiopathic hyposmia has also been associated with an increased risk of PD. The relationship between risk factors for PD and impaired olfactory function has not been evaluated in relatives of PD patients. We conducted a mail survey of odor identification ability in 173 first-degree relatives of PD patients using the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Respondents also completed a questionnaire inquiring about risk factors for PD including caffeine consumption, tobacco use, exercise, and exposures to heavy metals, well-water, and pesticides. There was a direct relationship between olfactory performance and lifetime caffeine intake. After adjustment for age, gender, and smoking status, subjects who reported drinking 2 to 3 cups of caffeinated beverages per day (2.6 points higher 95% CI: 0.5, 4.5) and 4 or more cups per day (3.7 points higher, 95% CI: 0.6, 6.7) had significantly better UPSIT scores than those who consumed less than I cup per day. There was no significant relationship between olfactory performance and other risk factors. In conclusion, abnormal olfaction is associated with significantly lower lifetime caffeine consumption in first-degree relatives of PD patients. Further research is warranted to determine whether a history of lower caffeine consumption confers additional risk for the development of PD in hyposmic relatives of PD patients. (c) 2007 Movement Disorder Society.
引用
收藏
页码:2249 / 2255
页数:7
相关论文
共 36 条
  • [1] Midlife adiposity and the future risk of Parkinson's disease
    Abbott, RD
    Ross, GW
    White, LR
    Nelson, JS
    Masaki, KH
    Tanner, CM
    Curb, JD
    Blanchette, PL
    Popper, JS
    Petrovitch, H
    [J]. NEUROLOGY, 2002, 59 (07) : 1051 - 1057
  • [2] Frequency of bowel movements and the future risk of Parkinson's disease
    Abbott, RD
    Petrovitch, H
    White, LR
    Masaki, KH
    Tanner, CM
    Curb, JD
    Grandinetti, A
    Blanchette, PL
    Popper, JS
    Ross, GW
    [J]. NEUROLOGY, 2001, 57 (03) : 456 - 462
  • [3] Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
    Ascherio, A
    Zhang, SMM
    Hernán, MA
    Kawachi, I
    Colditz, GA
    Speizer, FE
    Willett, WC
    [J]. ANNALS OF NEUROLOGY, 2001, 50 (01) : 56 - 63
  • [4] Pesticide exposure and risk for Parkinson's disease
    Ascherio, Alberto
    Chen, HonPei
    Weisskopf, Marc G.
    O'Reilly, Eilis
    McCullough, Marjorie L.
    Calle, Eugenia E.
    Schwarzschild, Michael A.
    Thun, Michael J.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 (02) : 197 - 203
  • [5] Smoking, alcohol, and coffee consumption preceding Parkinson's disease - A case-control study
    Benedetti, MD
    Bower, JH
    Maraganore, DM
    McDonnell, SK
    Peterson, BJ
    Ahlskog, JE
    Schaid, DJ
    Rocca, WA
    [J]. NEUROLOGY, 2000, 55 (09) : 1350 - 1358
  • [6] Acute and reversible parkinsonism due to organophosphate pesticide intoxication - Five cases
    Bhatt, MH
    Elias, MA
    Mankodi, AK
    [J]. NEUROLOGY, 1999, 52 (07) : 1467 - 1471
  • [7] BRAAK H, 2002, J NEUROL S3, V249, pS1
  • [8] Physical activity and the risk of Parkinson disease
    Chen, H
    Zhang, SM
    Schwarzschild, MA
    Hernán, MA
    Ascherio, A
    [J]. NEUROLOGY, 2005, 64 (04) : 664 - 669
  • [9] Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
    Chen, HL
    Jacobs, E
    Schwarzschild, MA
    McCullough, ML
    Calle, EE
    Thun, MJ
    Ascherio, A
    [J]. ANNALS OF NEUROLOGY, 2005, 58 (06) : 963 - 967
  • [10] OLFACTORY DYSFUNCTION IN PARKINSONISM - A GENERAL DEFICIT UNRELATED TO NEUROLOGIC SIGNS, DISEASE STAGE, OR DISEASE DURATION
    DOTY, RL
    DEEMS, DA
    STELLAR, S
    [J]. NEUROLOGY, 1988, 38 (08) : 1237 - 1244